I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
De Marzo, Angelo M.
10
results:
french X
Search for persons
X
Format
Online (9)
Print (1)
Mediatypes
Books (1)
Articles (Online) (9)
Sorted by: Relevance
Sorted by: Year
?
1
Le droit social en dialogue
mélanges en l'honneur Marie-Ange Moreau ; européanisation... Mélanges
Marzo, Claire
;
Trudeau, Giles
;
Robin-Olivier, Sophie
... , [2022]
Copies:
Juridicum
: h jur 002 morea/65
?
2
033 L'infusion chronique et centrale d'oxytocine améliore l..:
Deblon, N.
;
Veyrat-Durebex, C.
;
Bourgoin, L.
...
Diabetes & Metabolism. 37 (2011) 1 - p. A8-A9 , 2011
Link:
https://doi.org/10.1016/..
?
3
Tolérance et efficacité à long terme du bimékizumab chez le..:
Dougados, M.
;
Deodhar, A.
;
Navarro-compán, V.
...
Revue du Rhumatisme. 90 (2023) - p. A186-A188 , 2023
Link:
https://doi.org/10.1016/..
?
4
Sécurité et efficacité à long terme du tofacitinib chez des..:
Gladman, D.
;
Dougados, M.
;
Marzo-Ortega, H.
...
Revue du Rhumatisme. 90 (2023) - p. A172 , 2023
Link:
https://doi.org/10.1016/..
?
5
Le bimékizumab améliore les principaux symptômes rapportés ..:
Dougados, M.
;
Mease, P.J.
;
Deodhar, A.
...
Revue du Rhumatisme. 89 (2022) - p. A239-A240 , 2022
Link:
https://doi.org/10.1016/..
?
6
Réponse clinique au traitement par ixékizumab chez des pati..:
Marzo-Ortega, H.
;
Juanola, X.
;
Okano, T.
...
Revue du Rhumatisme. 88 (2021) - p. A128 , 2021
Link:
https://doi.org/10.1016/..
?
7
Ixékizumab dans la spondyloarthrite axiale non-radiographiq..:
Deodhar, A.
;
Van Der Heijde, D.
;
Gensler, L.
...
Revue du Rhumatisme. 87 (2020) - p. A165-A166 , 2020
Link:
https://doi.org/10.1016/..
?
8
Le sécukinumab améliore les signes et symptômes de la spond..:
Goupille, P.
;
Braun, J.
;
Blanco, R.
...
Revue du Rhumatisme. 87 (2020) - p. A175-A176 , 2020
Link:
https://doi.org/10.1016/..
?
9
Facteurs de risque cardiovasculaire chez des patients attei..:
López-Medina, Clementina
;
Jiménez-Gómez, Yolanda
;
Moltó, Anna
...
Revue du Rhumatisme. 86 (2019) 1 - p. 63-69 , 2019
Link:
https://doi.org/10.1016/..
?
10
L'aprémilast, un inhibiteur oral de la phosphodiestérase 4,..:
Mease, P.J.
;
Marzo-Ortega, H.
;
Airi, P.
...
Revue du Rhumatisme. 83 (2016) - p. A212-A213 , 2016
Link:
https://doi.org/10.1016/..
1-10
Related subjects
Arbeitsrecht und Sozialrecht. Europäische Sozialcharta